COSCIENS Biopharma Inc 20-F, filed Mar 25, 2026
COSCIENS Biopharma Inc. (CSCIF)
20-F
2026-03-25
For: 2025-12-31
View Original
Added on
April 06, 2026
About this 20-F
COSCIENS Biopharma Inc filed this 20-F on March 25, 2026, covering the fiscal year ended December 31, 2025.
Headline figures
Fiscal year ended December 31, 2025, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $7.5M
- down 21.8% from $9.59M a year earlier
- Net loss
- $10.36M
- compared with a net loss of $15.31M a year earlier
- Diluted EPS
- -$3.27
- compared with -$5.93 a year earlier